About Us

Eve del Rio, M.D., Ph.D.
Company Founder and President

Dr. del Rio brings a quarter-century of experience to medical and regulatory consulting.

Prior to building a full-service pharmaceutical and medical device consulting practice, she was vice president, clinical research and operations, for a disease/medication management service and specialty pharmacy/data management operation that optimized and rationalized drug therapy.

Previously, as director of clinical research for Novartis Consumer Health, Dr. del Rio was responsible for conducting research and drafting FDA submissions in several areas of new pharmaceuticals, developing global regulatory and clinical strategies to support Rx-toOTC switch applications.

Her work on validating clinical trial methods based on Good Clinical Practice (GCP)-compliant clinical trials has been published in numerous peer-reviewed journals. She also chaired international clinical team meetings and investigators' meetings, led a clinical research staff, and oversaw a considerable R&D budget.

Dr. del Rio received her M.D. and Ph.D. from Columbia University College of Physicians and Surgeons, as well as B.A. in Zoology from Drew University , Madison, N.J.

Donald P Reitberg, PharmD.

Dr. Reitberg has more than 30 years of experience in the pharmaceutical industry. He is a registered pharmacist, pharmacologist, pharmacokineticist and clinical research/regulatory professional who has worked in many therapeutic areas and in all phases of drug development. 

Prior to working as a consultant and developing start-up companies, Don served as Vice President of Scientific Affairs for Novartis Consumer Health where he managed all aspects of new product development and support for existing products. He also served as a clinical research/medical affairs director for Pfizer, Sterling Drug, American Home Products, Smithkline Beecham, and American Home Products. 

Dr. Reitberg received his B.S. degree in Pharmacy fro
m the University of Utah, Salt Lake City, UT, and his Doctor of Pharmacy degree from the State University of New York at Buffalo (SUNYAB), Buffalo, NY. He completed a fellowship in pharmacokinetics, clinical pharmacology and clinical trials management at Millard Fillmore Hospital jointly with SUNYAB, Buffalo, NY. He is a member of the American Society for Clinical Pharmacology and Therapeutics and the American Pharmaceutical Association.

 Robert Smit
h, PhD

Dr. Smith has more than 30 years of experience in the pharmaceutical industry. He has provided or supervised the statistical support for the design, analysis, and reporting of clinical trials in many therapeutic areas and in all phases of drug development including life cycle management. He has contributed to several marketing applications. He has served as the unblinded statistical liaison to Data Monitoring Committees and has been a voting member of other DMCs.

Prior to forming RAS Statistics, LLC, Bob served as Director of Global Biometric Sciences at Bristol-Myers Squibb in Princeton, NJ, where he oversaw the statistical and clinical programming support for all clinical pharmacology and translational medicine studies. He participated on and/or led interdisciplinary teams on process improvement, response to draft regulatory Guidances for Industry, and due diligence evaluations of candidate service providers. He has also directed the statistical support for later phase clinical studies in the cardiovascular, metabolic, infectious, and inflammatory disease therapeutic areas, and began his pharmaceutical career working in the cardiovascular and oncology therapeutic areas at CIBA-Geigy.

Bob has been an instructor on statistical methodology for the Pharmaceutical Education & Research Institute (PERI), and has authored or co-authored several papers and presentations on applications of statistics to clinical trials.

135 Walter's Brook Drive
Bridgewater, NJ 08807-5633
(908) 672-6388: Office